No cure; management focuses on symptom relief and supportive care; lung or liver transplant may be considered in severe cases
Alpha-1 antitrypsin deficiency is a genetic disorder that can lead to lung and liver disease. It occurs when the body does not produce enough of a protein called alpha-1 antitrypsin. Treatment may involve medications and, in some cases, lung or liver transplantation.
Genetic disorder leading to a deficiency of alpha-1 antitrypsin, affecting the lungs and liver
Lung problems (chronic obstructive pulmonary disease – COPD), liver disease
Genetic testing, lung function tests
Variable; depends on the severity of the condition
Chronic obstructive pulmonary disease, liver disease
Genetic mutations affecting the SERPINA1 gene
Supportive care, management of symptoms, sometimes lung/liver transplant
Supportive care, management of symptoms, sometimes lung/liver transplant
Autosomal recessive genetic disorder; can lead to lung and liver problems
Lifestyle modifications and supportive care are important for management
For personalized advice and care, always seek the assistance of healthcare professionals. This information is meant for general understanding and not as a replacement for professional medical advice.
Share: